CTKB
- Cytek Biosciences, Inc.
()
Overview
Company Summary
Cytek Biosciences, Inc. (CTKB) is a biotechnology company that focuses on developing and manufacturing advanced flow cytometry instruments for use in scientific research, clinical diagnostics, and drug development.
Flow cytometry is a technique used to analyze and measure characteristics of individual cells or particles in a fluid sample. It provides valuable information about cell count, cell size, cell cycle analysis, and identification of specific cell populations based on the expression of certain markers or proteins.
Cytek Biosciences specializes in designing and producing high-quality, innovative flow cytometry solutions that offer researchers and clinicians enhanced capabilities in cell analysis. Their instruments are known for their superior sensitivity, multiplexing capacity (the ability to detect multiple biomarkers simultaneously), and user-friendly software interfaces.
The company is committed to advancing scientific discoveries and personalized medicine by providing researchers, clinicians, and pharmaceutical companies with reliable tools for studying diseases, discovering new therapeutic targets, assessing drug efficacy, and developing precision medicine approaches.
In addition to their flow cytometry platforms, Cytek Biosciences also offers a range of related products such as fluorochrome-conjugated antibodies, reagents, and software analysis tools. These integrated solutions enable customers to optimize their experimental designs and obtain meaningful insights from complex biological samples.
With a strong focus on innovation and customer satisfaction, Cytek Biosciences continues to play a vital role in advancing the field of flow cytometry and contributing to advancements in drug discovery, immunology, cancer research, and other areas of life sciences.